Drug Trial Radar · NCT06052267
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
2,769
Actual
Start
Aug 30, 2023
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D LLCTeva (TEVA)
- Sponsor type
- Industry
- First posted
- Sep 25, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic module multidose dry powder inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs). Secondary Objectives: To evaluate the efficacy of Fp/ABS low dose compared to ABS and the effect on systemic corticosteroid (SCS) exposure To evaluate the safety and tolerability of Fp/A BS The duration for each participant will be a minimum of 28 weeks including 2 weeks of screening, 2-4 weeks of run-in period and a double blind treatment period of minimum 24 weeks, however due to the event-driven nature of this study, the duration may range up to approximately 42 months depending on the timing when the participant was enrolled to the study, and when the study reaches its completion criteria
Conditions
- Asthma
Interventions
TEV-56248Drug
Fluticasone Propionate/Salbutamol Sulfate. Oral inhalation powder.
Albuterol sulfateDrug
Oral inhalation powder
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Severe Clinical Asthma Exacerbation (CAE) with High Dose (HD) Fp/ABS eMDPITime frame: Up to 42 months
Locations
391 sites in 22 countries. Site status is shown where the registry gives one.
AllerVie Clnical Research
Birmingham, Alabama
The University of Alabama at Birmingham
Birmingham, Alabama
SEC Clinical Research
Dothan, Alabama
One of a Kind Clinical Research Center LLC
Paradise Valley, Arizona
Mayo Clinic
Scottsdale, Arizona
Novak Clinical Research
Tucson, Arizona
Kern Research, Inc
Bakersfield, California
Clinical Research of Central California, LLC
Fresno, California
Allergy and Asthma Specialists Medical Group
Huntington Beach, California
Orso Health
La Jolla, California
IMAX Clinical Trials
La Palma, California
Long Beach Clinical Trials
Long Beach, California
Ark Clinical Research, LLC
Long Beach, California
Ricardo Antonio Tan Inc
Los Angeles, California
One of a Kind Clinical Research Center LLC
Napa, California
California Medical Research Associates Inc.
Northridge, California
Riviera Allergy Medical Center
Redondo Beach, California
Velocity Clinical Research, Banning
San Bernardino, California
Institute of HealthCare Assessment, Inc
San Diego, California
Allergy and Asthma Associates
San Jose, California
Bensch Clinical Research LLC
Stockton, California
Allianz Research Institute
Westminster, California
Allianz Research Institute
Aurora, Colorado
CRN Clinical Research Network LLC/Asthma and Allergy Associates P.C.
Colorado Springs, Colorado
OptumCare Colorado Springs LLC
Colorado Springs, Colorado
Velocity Clinical Research
Englewood, Colorado
Emerson Clinical Research Institute
Washington D.C., District of Columbia
Florida Center for Allergy and Asthma Research
Aventura, Florida
Renaissance Research and Medical Group
Cape Coral, Florida
Cenara Clinical Research
Cutler Bay, Florida
D & H Doral Research Centers
Doral, Florida
Finlay Medical Research Corp
Greenacres City, Florida
Direct Helpers Research Center, Inc.
Hialeah, Florida
New Life Research Institute, LLC
Hialeah, Florida
Homestead Medical Research
Homestead, Florida
Nemours Children Clinic
Jacksonville, Florida
Clinical Site Partner, LLC DBA Flourish Research
Leesburg, Florida
D & H Pompano Research Centers, Inc.
Margate, Florida
EMDA Clinical Research
Miami, Florida
Finlay Medical Research
Miami, Florida
Showing 40 of 391 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.